RCUS Stock Analysis: Buy, Sell, or Hold?
RCUS - Arcus Biosciences, Inc.
$31.00
0.75 (2.48%)
▲
5d:
+27.52%
30d:
+29.33%
90d:
+46.16%
HOLD
MODERATE Confidence
Analysis Updated: Jun 26, 2026 12:00 AM ET
Earnings: Aug 05, 2026
Get Alerted When RCUS Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD - EXTENDED: RCUS is 14.8% above its trading range ($27.00). Fundamentals are solid but entry is stretched. Hold existing positions; wait for pullback to add new shares.
📊 HOLD - EXTENDED: RCUS is 14.8% above its trading range ($27.00). Fundamentals are solid but entry is stretched. Hold existing positions; wait for pullback to add new shares.
In-depth Analysis How we analyze
Valuation Analysis: RCUS is currently trading at $31.00, which is considered extended relative to its 30-day fair value range of $22.63 to $27.00.
Technical Outlook: Technically, RCUS is in a uptrend. The price is approaching resistance at $31.44. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: RCUS has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $35.75 (+15.3%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, RCUS is in a uptrend. The price is approaching resistance at $31.44. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: RCUS has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $35.75 (+15.3%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$22.63 -
$27.00
Company Quality Score
55/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
50.0%
Protect Your Profits
RCUS is technically overbought (RSI 75). Consider hedging now to protect against a potential pullback while keeping your upside.
View Profit Protection PlanAll Signals
- BEARISH: Price significantly overextended (+14.8% above its trading range)
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
- BULLISH: Trading below Wall St target ($35.75)
Trading Range Analysis
30-Day Trading Range
$22.63 -
$27.00
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$23.27
Resistance Level
$31.44
Current Trend
Uptrend
Technical data as of
Jun 26, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-9.99
Wall Street Target
$35.75
(+15.3%)
Revenue Growth (YoY)
-39.3%
Profit Margin
-156.4%
Share & Embed Analysis
Last updated: June 27, 2026 2:55 PM ET
Data refreshes hourly during market hours. Next update: 3:55 PM
Data refreshes hourly during market hours. Next update: 3:55 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is RCUS showing a specific setup today?
Insider Activity (6 Months)
0
Buys
2
Sells
Net
INSIDERS SELLING
Recent Transactions
Juan C Jaen
SELL
31823 shares
2026-01-05
Robert C Goeltz II
SELL
6552 shares
2025-12-31
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
AXSM
Axsome Therapeutics Inc |
STRONG BUY
19 analysts |
$276 | 59 HOLD |
|
CYTK
Cytokinetics Inc |
STRONG BUY
21 analysts |
$105 | 61 BUY |
|
INCY
Incyte Corporation |
HOLD
27 analysts |
$109 | 67 BUY |
|
VKTX
Viking Therapeutics Inc |
STRONG BUY
19 analysts |
$93 | 56 HOLD |
|
CRNX
Crinetics Pharmaceutical… |
STRONG BUY
17 analysts |
$83 | 60 HOLD |
Advanced RCUS Option Strategies
Professional options setups generated by AI based on today's RCUS price and gamma walls.
